CT Post – Connecticut’s expanded lawsuit against Purdue Pharma and its owners positions the state to more aggressively pursue its claims, but does not assure a full redress of its allegations of deceptive marketing and fraudulent finances against the much-maligned OxyContin maker.
Robert Bird
British Drug Maker Indivior Indicted On Fraud And Conspiracy Charges In The U.S.
Many sue OxyContin maker, but not its own city: Stamford
Opioids: Boston trial opens what could be year of reckoning for executives
Purdue Pharma to research non-opioid treatments
Daily Heralds – Purdue Pharma, the controversial maker of OxyContin, and eyecare-pharmaceutical firm Ocular Therapeutix has announced a research partnership aiming to develop non-opioid pain treatments.
Read article